MedAxiom, the nation’s leading cardiovascular healthcare membership organization and performance community, is excited to announce its industry partnership with Genetesis, Inc., a medical technology company with a vision to improve patients’ cardiovascular health, outcomes, and quality of life.
“Genetesis is striving to improve efficiency in ruling out and detecting heart disease through magnetocardiography (MCG), an imaging modality that measures magnetic fields produced by the natural electrical activity of the heart. Genetesis’s CardioFlux has overcome adoption challenges and expenses by eliminating the need for magnetically shielded rooms and liquid helium cooling.” said Joe Sasson Ph.D., EVP of MedAxiom Ventures. “We are excited to welcome them as a MedAxiom Industry Partner and bring awareness and understanding of their opportunities to our membership community.”